Related Experiment Video
Updated: May 17, 2025

Influenza A Virus Studies in a Mouse Model of Infection
Published on: September 7, 2017
Influenza virus: Genomic insights, evolution, and its clinical presentation
Rishika Jain1, Himanshu Sharma1, Lindomar Pena2
1Department of Zoology, Hansraj College, University of Delhi, Mahatma Hansraj Marg, Malkaganj, Delhi, 110007, India.
Abstract:
Influenza viruses belong to the family Orthomyxoviridae and have been a concern for public health due to frequent epidemics and sporadic waves of pandemics. According to WHO, seasonal strains of the influenza A virus (IAV) infect 3 to 5 million people every year and result in 0.29-0.65 million deaths globally. Among all proteins of IAV, the hemagglutinin (HA) and neuraminidase (NA) have high mutation rates and have been reported to undergo antigenic drift and shift leading to novel strains. Hence continuous revision in drugs and vaccines regime is an economic burden as these reassortments can cause high morbidity among the immunologically naive population. Infection rates are higher among older age groups, infants and patients reported with other respiratory distress. Routine diagnostic tests include reverse transcription polymerase chain reaction (RT-PCR), viral culture, and immunofluorescence assays; however, the diagnosis may be hindered due to the resemblance of the clinical presentation of other respiratory viruses with influenza viruses. Here we present a comprehensive review which sheds light on the genomic structure, evolution, pathogenicity and clinical presentation of influenza virus that can help to distinguish it from other respiratory viruses. A detailed analysis will ultimately pave the way for the development of more effective antiviral drugs and a universal vaccine.
Insights
Influenza A virus (IAV) poses a significant global health threat, causing millions of infections and hundreds of thousands of deaths annually. This review details IAV
Area of Science:
- Virology
- Public Health
- Immunology
Background:
- Influenza A virus (IAV) is a major global health concern, causing annual epidemics and occasional pandemics.
- High mutation rates of hemagglutinin (HA) and neuraminidase (NA) proteins lead to novel strains, necessitating continuous vaccine and drug updates.
- IAV infections disproportionately affect the elderly, infants, and individuals with respiratory conditions.
Purpose of the Study:
- To provide a comprehensive review of influenza virus.
- To elucidate the genomic structure, evolution, pathogenicity, and clinical presentation of influenza virus.
- To aid in distinguishing influenza from other respiratory viruses and guide the development of new antivirals and vaccines.
Main Methods:
- Literature review and analysis of existing data on influenza virus.
- Examination of genomic, evolutionary, and pathogenic factors of IAV.
- Comparison of clinical presentations of influenza and other respiratory viruses.
Main Results:
- Influenza virus exhibits rapid evolution through antigenic drift and shift, driven by HA and NA protein mutations.
- Clinical diagnosis can be challenging due to symptom overlap with other respiratory viruses.
- Understanding IAV's characteristics is crucial for effective public health strategies.
Conclusions:
- A detailed understanding of influenza virus biology is essential for developing effective countermeasures.
- This review provides insights to differentiate influenza from other respiratory illnesses.
- Further research can accelerate the development of novel antiviral therapies and a universal influenza vaccine.
Related Concept Videos
Viral Mutations
Viral Recombination
Leaky Scanning
Single Nucleotide Polymorphisms-SNPs

